Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Director, Financial Planning and Analysis, Clinical, will be a key member of the FP&A team reporting to the VP of FP&A. The focus of this position will be managing the planning processes and serving as the business partner to the Clinical and Medical Affairs organizations and assisting the VP of FP&A on overall planning process strategy and management. This position will also interact closely with the accounting team on the month end closing process.
Responsibilities
- FP&A business partner to the Clinical and Medical Affairs organizations, and BEAM-302 and BEAM-301 programs.
- Oversee planning cycle activities and review and ensure accuracy of plan data for all partner functions and programs.
- Conduct monthly budget vs. actual analysis for partner functions and programs, and finance/management results.
- Track risks and opportunities to the annual budget and enter material changes into rolling forecast.
- Assist in the overall budget, LRP, and forecast processes outside of partnership duties.
- Partner with Sourcing on contract and change order reviews for significant Clinical Trial Agreements to ensure competitive costing and budget compliance.
- Attend monthly Clinical accrual meetings to ensure accuracy of expense and SOX compliance.
- Attend quarterly milestone meetings to ensure accuracy of expense and future projections in forecast.
- Special projects as required.
Requirements
- 8+ years of FP&A experience; biotech industry experience strongly preferred.
- Bachelor’s degree in finance or accounting or equivalent.
- Financial statement knowledge and understanding of US GAAP.
- Strong team player that has a customer service approach and is solution oriented.
- Ability to work within and meet all deadlines while executing on multiple deliverables.
- Enjoy working in a fast-paced, high-volume environment.
- Comfort utilizing and incorporating available AI tools into work processes.
- Advanced understanding of Excel, Adaptive Insights, and ERP systems (preferably NetSuite or SAP).
The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.
Skills Required
- Bachelor's degree in finance, accounting, or equivalent
- 15 years of relevant experience
- 8 or more years of overall FP&A experience
- At least 2 years of commercial FP&A experience
- Biotechnology industry experience
- Financial statement knowledge and understanding of US GAAP
- Advanced financial modeling expertise, including building models from the ground up in Excel or planning tools
- Advanced understanding of Excel and Adaptive Insights
- Experience with ERP systems, preferably NetSuite or SAP
- Ability to use AI tools in work processes
- Ability to meet deadlines while managing multiple deliverables
- Ability to work effectively in a fast-paced, high-volume environment
- Strong teamwork, customer-service orientation, and solution-oriented approach
What We Do
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes. Our dream is to provide life-long cures for patients suffering from serious diseases. The Beam Team Is: • A community of fearless innovators • Rigorous and honest in our research • Listening with open minds • Committed to each other
